Showing results (51-60 of 613) with videos related to
Sort By:
Pageof 62
Focus (American Psychiatric Publishing)|November 20, 2024
Renal Impairment and Dose Adjustment of Long-Acting Injectable Antipsychotics: Are We Getting It Right? A Case ReportColette Raphaël, Gary Remington, Ofer AgidJournal of Clinical Psychopharmacology|September 15, 2016
Incidence of Antipsychotic-Associated Side Effects: Impact of Clinician Versus Patient Ratings and Change Versus Absolute ScoresHiroyoshi Takeuchi, Gagan Fervaha, Gary RemingtonJMIR Research Protocols|May 8, 2013
Evaluation of active transition, a website-delivered physical activity intervention for university students: pilot studyMatthew Kwan, Guy Faulkner, Steven BrayHealth Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice|October 16, 2020
Evidence-based recommendations to assist adults with depression to become lifelong moversMichelle Fortier, Taylor McFadden, Guy FaulknerExpert Opinion on Pharmacotherapy|July 1, 2010
Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse preventionOfer Agid, George Foussias, Gary RemingtonExpert Opinion on Emerging Drugs|September 4, 2008
Emerging drugs for schizophreniaOfer Agid, Shitij Kapur, Gary RemingtonPsychiatry Research|August 21, 2016
Reliability of a patient-reported outcome measure in schizophrenia: Results from back-to-back self-ratingsHiroyoshi Takeuchi, Gagan Fervaha, Gary RemingtonSchizophrenia Research|June 8, 2014
Mean platelet volume in schizophrenia unaltered after 1year of clozapine exposureJimmy Lee, Valerie Powell, Gary RemingtonThe Journal of Clinical Psychiatry|February 5, 2015
Suicide in schizophrenia: an observational study of coroner records in TorontoMark Sinyor, Ayal Schaffer, Gary RemingtonCNS Drugs|December 25, 2009
Progress in defining optimal treatment outcome in schizophreniaGary Remington, George Foussias, Ofer AgidPageof 62